Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 14, 2024 07:30 ET | Source: Tavros Therapeutics

Tavros Therapeutics Achieves Two Milestone Payments in its Collaboration with Vividion Therapeutics

DURHAM, N.C., May 14, 2024 (GLOBE NEWSWIRE) -- Tavros Therapeutics, Inc., a precision oncology platform company, today announced that the Company has achieved two milestone payments in its...
April 27, 2023 08:19 ET | Source: Tavros Therapeutics

Tavros Therapeutics and OpenBench Expand Strategic Collaboration for Small Molecule Drug Discovery

Multi-target collaboration leverages Tavros’ proprietary functional genomic discovery program and OpenBench’s screening platform Partnership streamlines drug development for novel cancer therapies ...
October 12, 2022 07:30 ET | Source: Tavros Therapeutics

Tavros Therapeutics and Vividion Therapeutics Announce Strategic Collaboration to Discover and Enhance Targeted Oncology Programs

Tavros to receive $17.5M upfront, up to $430.5M in milestone payments for initial four programs, and certain royalties over agreement term Vividion will have rights to opt-in to up to five more...
September 27, 2022 07:30 ET | Source: Tavros Therapeutics

Tavros Therapeutics Raises $7.5 Million in Oversubscribed Seed II Round

DURHAM, N.C., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Tavros Therapeutics, a precision oncology platform company leading the new frontier of targeted therapies exploiting tumors’ genetic vulnerabilities,...